Peculiarities of persons who inject drugs among patients with HIV–tuberculosis coinfection registered in 4^th District TB Unit Bucharest during 2009–2018

1 Tuberculosis surveillance and monitoring in Europe 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/tuberculosis-surveillance-monitoring-Europe-2021.pdf [Accessed 2nd July 2021]. Search in Google Scholar

2 Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. Tuberculosis and HIV co-infection. PLoS Pathogens. 2012;8(2): e1002464. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22363214 [Accessed 16th October 2020] Search in Google Scholar

3 Diedrich CR, Flynn JL. HIV-1/mycobacterium tuberculosis coin-fection immunology: how does HIV-1 exacerbate tuberculosis? Infection and Immunity. 2011;79(4): 1407–1417. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21245275 [Accessed 16th October 2020]. Search in Google Scholar

4 Meijerink H, Wisaksana R, Lestari M, Meilana I, Chaidir L, van der Ven AJAM, et al. Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia. Journal of the International AIDS Society. 2015;18(1): 19317. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25690530 [Accessed 19th October 2020]. Search in Google Scholar

5 Winter JR, Stagg HR, Smith CJ, Brown AE, Lalor MK, Lipman M, et al. Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV. Acquired Immune Deficiency Syndrome. 2017;31(17): 2403–2413. Available from: https://journals.lww.com/00002030-201711130-00010 [Accessed 25th February 2021]. Search in Google Scholar

6 Oprea C, Ianache I, Calistru P, Nica M, Ruta S, Smith C, et al. Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users. HIV Medicine. 2018;19(5): 316–323. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/hiv.12576 [Accessed 15th October 2020]. Search in Google Scholar

7 Zaharie A-M, Tigau M. Negative impact factors in HIV- tuberculosis. Maedica Journal of Clinical Medicine. 2021;16(2): 179–183. Available from: doi.org/10.26574/maedica.2021.16.2.179. [Accessed 2nd July 2021]. Search in Google Scholar

8 Romania, Country Drug Report 2019. www.emcdda.europa.eu. Available from: https://www.emcdda.europa.eu/publications/country-drug-reports/2019/romania_en. [Accessed 16th March 2021]. Search in Google Scholar

9 WHO. Tuberculosis and HIV. WHO. 2017. Available from: http://www.who.int/hiv/topics/tb/about_tb/en/ [Accessed 15th March 2021]. Search in Google Scholar

10 Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, et al. HIV outbreaks among people who inject drugs in Europe, North America, and Israel. The Lancet HIV. 2020;7: e434–e442. Elsevier Ltd. Available from: https://pubmed.ncbi.nlm.nih.gov/32504576 [Accessed 15th March 2021]. Search in Google Scholar

11 Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Eurosurveillance. 2011;16: 20032. Available from: https://pubmed.ncbi.nlm.nih.gov/22172301/ [Accessed 15th March 2021]. Search in Google Scholar

12 Oprea C, Ceausu E, Ruta S. Ongoing outbreak of multiple blood-borne infections in injecting drug users in Romania. Public Health. 2013;127(11): 1048–1050. Available from: https://pubmed.ncbi.nlm.nih.gov/24239282/ [Accessed 15th March 2021]. Search in Google Scholar

13 Temereanca A, Oprea C, Wertheim JO, Ianache I, Ceausu E, Cernescu C, et al. HIV transmission clusters among injecting drug users in Romania. Roumanian Biotechnological Letters. 2017;22(1): 12307–12315. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29213206 [Accessed 15th March 2021]. Search in Google Scholar

14 Pacheco PRG, Zara ALSA, Silva E Souza LC, Turchi MD. Late onset of antiretroviral therapy in adults living with HIV in an urban area in Brazil: prevalence and risk factors. Journal of Tropical Medicine. 2019;2019: 5165313. Search in Google Scholar

15 Date statistice privind consumul de droguri în România 2020 - Seturi de date - data.gov.ro. Available from: https://data.gov.ro/dataset/date-statistice-privind-consumul-de-droguri-in-romania-2020 [Accessed 16th March 2021]. Search in Google Scholar

16 Ruta S, Sultana C, Oprea C, Vagu C, Ceausu E, Cernescu C. HCV non-1b genotypes in injecting drug users from Romania. Journal of Infection in Developing Countries. 2016;10(5): 523–527. Available from: https://jidc.org/index.php/journal/article/view/7019 [Accessed 15th March 2021]. Search in Google Scholar

17 Oprea C, Ianache I, Calistru PI, Nica M, Ruta S, Smith C, et al. Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users. HIV Medicine. 2018;19(5): 316–323. Available from: https://pubmed.ncbi.nlm.nih.gov/29464834/ [Accessed 15th March 2021]. Search in Google Scholar

18 Díez M, Bleda MJ, Alcaide J, Caloto T, Castells C, Cardenal JI, et al. Determinants of patient delay among tuberculosis cases in Spain. European Journal of Public Health. 2004;14(2): 151–155. Available from: https://pubmed.ncbi.nlm.nih.gov/15230500/ [Accessed 15th March 2021]. Search in Google Scholar

19 Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Des Jarlais DC. Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Reports. 1994;109(3): 319–327. Available from: /pmc/articles/PMC1403496/?report=abstract [Accessed 15th March 2021]. Search in Google Scholar

20 Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. Acquired Immune Deficiency Syndrome. 2005;19: S179–S189. Lippincott Williams and Wilkins. Available from: https://pubmed.ncbi.nlm.nih.gov/16251816/ [Accessed 15th March 2021]. Search in Google Scholar

21 Pablos-Méndez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. The American Journal of Medicine. 1997;102(2): 164–170. Available from: https://pubmed.ncbi.nlm.nih.gov/9217566/ [Accessed 15th March 2021]. Search in Google Scholar

22 Haldane V, Cervero-Liceras F, Chuah FL, Ong SE, Murphy G, Sigfrid L, et al. Integrating HIV and substance use services: a systematic review. Journal of the International AIDS Society. 2017;20: 21585. Wiley Blackwell. Available from: https://www.who.int/hiv/topics/tb/about_tb/en/ [Accessed 15th March 2021]. Search in Google Scholar

23 Grenfell P, Baptista Leite R, Garfein R, de Lussigny S, Platt L, Rhodes T. Tuberculosis, injecting drug use and integrated HIVTB care: a review of the literature [Internet]. Vol. 129, Drug and Alcohol Dependence. Drug Alcohol Depend; 2013 [cited 2022 May 16]. p. 180–209. Available from: https://pubmed.ncbi.nlm.nih.gov/23306095/ Search in Google Scholar

24 Winter JR, Stagg HR, Smith CJ, Brown AE, Lalor MK, Lipman M, et al. Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV. Acquired Immune Deficiency Syndrome. 2017;31(17): 2403–2413. Available from: https://journals.lww.com/00002030-201711130-00010 [Accessed 16th May 2022]. Search in Google Scholar

25 Nagot N, Hai VV, Dong TTT, Hai OKT, Rapoud D, Hoang GT, et al. Alarming tuberculosis rate among people who inject drugs in vietnam. Open Forum Infectious Diseases. 2022;9(2): ofab548. Available from: /pmc/articles/PMC8801226/ [Accessed 16th May 2022]. Search in Google Scholar